Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine/threonine kinase Mos

Neurobiology of Aging

Volumn 17, Issue 2, 1996, Pages 235-241

  James, Nicholas D ^a,e   Davis, Daniel R ^b   Sindon, John ^b   Hanger, Diane P ^b   Brion, Jean Pierre ^c   Miller, Christopher C J ^b   Rosenberg, Michael P ^d   Anderton, Brian H ^b   Propst, Friedrich ^a,f  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

^d GLAXOSMITHKLINE   (United States)

^e QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^f UNIVERSITY OF VIENNA   (Austria)

Author keywords

GFAP; Gliosis; Mos; Neurofilament; Progressive neuronal degeneration; Protooncogene; Tau phosphorylation; Transgenic mouse; Vimentin

Indexed keywords

PROTEIN SERINE KINASE; PROTEIN SERINE THREONINE KINASE; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; GLIOSIS; IMMUNOREACTIVITY; MOUSE; NERVE DEGENERATION; NEUROFILAMENT; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE;

EID: 0029982615     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-4580(95)02068-3     Document Type: Article

References (57)

1. Berling, B.; Wille, H.; Röll, B.; Mandelkow, E.-M.; Garner, C.; Mandelkow, E. Phosphorylation of microtubule-associated proteins MAP2a,b and MAP2c at Ser136 by proline-directed kinases in vivo and in vitro. Eur. J. Cell Biol. 64:120-130; 1994.
2. Biernat, J.; Mandelkow, E.-M.; Schröter, C.; Lichtenberg-Kraag, B.; Steiner, B.; Berling, B.; Meyer, H.; Mercken, M.; Vanderneeren, A.; Goedert, M.; Mandelkow, E. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J. 11:1593-1597; 1992.
3. Binder, L. I.; Frankfurter, A.; Rebhun, L. I. The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101:1371-1378; 1985.
4. Brion, J.-P.; Guilleminot, J.; Couchie, D.; Nunez, J. Both adult and juvenile tau microtubule-associated proteins are axon specific in the developing and adult rat cerebellum. Neuroscience 25:139-146; 1988.
5. Brion, J.-P.; Hanger, D. P.; Bruce, M. T.; Couck, A. M.; Flament-Durand, J.; Anderton, B. H. Tau in Alzheimer neurofibrillary tangles: N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site. Biochem. J. 273:127-133; 1991.
6. Brion, J.-P.; Octave, J. N.; Couck, A. M. Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons. Neuroscience 63:895-909; 1994.
7. Brion, J.-P.; Smith, C.; Couck, A.-M.; Gallo, J.-M.; Anderton, B. H. Developmental changes in T phosphorylation: fetal τ is transiently phosphorylated in a manner similar to paired helical filament-τ characteristic of Alzheimer's disease. J. Neurochem. 61:2071-2080; 1993.
8. Cammer, W.; Tansey, F. A.; Brosnan, C. F. Gliosis in the spinal cords of rats with experimental allergic encephalomyelitis: Immunostaining of carbonic anhydrase and vimentin in reactive astrocytes. Glia 2:223-230; 1989.
9. Chomczynski, P.; Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159; 1987.
10. Coleman, M. P.; Anderton, B. H. Phosphate-dependent monoclonal antibodies to neurofilaments and Alzheimer neurofibrillary tangles recognize a synthetic phosphopeptide. J. Neurochem. 54:1548-1555; 1990.
11. Colledge, W. H.; Carlton, M. B. L.; Udy, G. B.; Evans, M. J. Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs. Nature 370:65-68; 1994.
12. Couchie, D.; Fages, C.; Bridoux, A. M.; Rolland, B.; Tardy, M.; Nunez, J. Microtubule-associated proteins and in vitro astrocyte differentiation. J. Cell Biol. 101:2095-2103; 1985.
13. Dahl, D. The vimentin-GFA protein transition in rat neuruglia cytoskeleton occurs at the time of myelination. J. Neurosci. Res. 6:741-748; 1981.
14. Dahl, D.; Rueger, D. C.; Bignami, A.; Weber, K.; Osborn, M. Vimentin, the 57,000 molecular weight protein of fibroblast filaments, is the major cytoskeletal component in immature glia. Eur. J. Cell Biol. 24:191-196; 1981.
15. Drewes, G.; Lichtenberg-Kraag, B.; Döring, F.; Mandelkow, E.-M.; Biernat, J.; Goris, J.; Dorée, M.; Mandelkow, E. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J. 11:2131-2138; 1992.
16. Freeman, R. S.; Kanki, J. P.; Ballantyne, S. M.; Pickham, K. M.; Donoghue, D. J. Effects of the v-mos oncogene on Xenopus development: Meiotic induction in oocytes and mitotic arrest in cleaving embryos. J. Cell Biol. 111:533-541; 1990.
17. Harrison, L.; Cheetham, M. E.; Calvert, R. A. Investigations of the changes in neuronal distribution and phosphorylation state of MAPIX during development. Dev. Neurosci. 15:68-76; 1993.
18. Hashimoto, N.; Watanabe, N.; Furuta, Y.; Tamemoto, H.; Sagata, N.; Yokoyama, M.; Okazaki, K.; Nagayoshi, M.; Takeda, N.; Ikawa, Y.; Aizawa, S. Parthenogenetic activation of oocytes in c-mos-deficient mice. Nature 370:68-71; 1994.
19. Herpers, M. J.; Ramaekers, F. C.; Aldeweireldt, J.; Moesker, O.; Slooff, J. Co-expression of glial fibrillary acidic protein- and vimentin-type intermediate filaments in human astrocytomas. Acta Neuropathol. Berl. 70:333-339; 1986.
20. Johnstone, A.; Thorpe, R. Immunochemistry in practice. Oxford, UK; Blackwell Scientific Publications; 1982.
21. Kobayashi, S.; Ishiguro, K.; Omori, A.; Takamatsu, M.; Arioka, M.; Imahori, K.; Uchida, T. A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule. FEBS Lett. 335: 171-175; 1993.
22. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685; 1970.
23. Larcher, J. C.; Boucher, D.; Ginzburg, I.; Gros, F.; Denoulet, P. Heterogeneity of tau proteins during mouse brain development and differentiation of cultured neurons. Dev. Biol. 154:195-204; 1992.
24. Lichtenberg-Kraag, B.; Mandelkow, E.-M.; Biernat, J.; Steiner, B.; Schröter, C.; Gustke, N.; Meyer, H. E.; Mandelkow, E. Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. Proc. Natl. Acad. Sci. USA 89:5384-5388; 1992.
25. Lovestone, S.; Reynolds, C. H.; Latimer, D.; Davis, D. R.; Anderton, B. H.; Gallo, J.-M.; Hanger, D.; Mulot, S.; Marquardt, B.; Stabel, S.; Woodgett, J. R.; Miller, C. C. J. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 4:1077-1086: 1994.
26. mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons. J. Neurosci. Res. 35:439-444; 1993.
27. Matsuo, E. S.; Shin, R.-W.; Billingsley, M. L.; Van DeVoorde, A.; O'Connor, M.; Trojanowski, J. Q.; Lee, V. M.-Y. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 13:989-1002; 1994.
28. mos. Virology 143:321-333; 1985.
29. Mizusawa, H.; Matsumoto, S.; Yen, S. H.; Hirano, A.; Rojas Corona, R. R.; Donnenfeld, H. Focal accumulation of phosphorylated neurofilaments within anterior horn cell in familial amyotrophic lateral sclerosis. Acta Neuropathol. Berl. 79:37-43; 1989.
30. 3F12 kinase: A novel MAP kinase expressed in a subset of neurons in the human nervous system. Neuron 14:67-78; 1995.
31. Nebreda, A. R.; Hill, C.; Gomez, N.; Cohen, P.; Hunt, T. The protein kinase mos activates MAP kinase kinase in vitro and stimulates the MAP kinase pathway in mammalian somatic cells in vivo. FEBS Lett. 333:183-187; 1993.
32. Nixon, R. A. The regulation of neurofilament protein dynamics by phosphorylation: Clues to neurofibrillary pathobiology. Brain Pathol. 3:29-38; 1993.
33. O'Keefe, S. J.; Wolfes, H.; Kiessling, A. A.; Cooper, G. M. Microinjection of antisense c-mos oligonucleotides prevents meiosis II in the maturing mouse egg. Proc. Natl. Acad. Sci. USA 86:7038-7042; 1989.
34. Oskarsson, M.; McClements, W. L.; Blair, D. G.; Maizel, J. V.; Vande Woude, G. F. Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus. Science 207:1222-1224; 1980.
35. Papasozomenos, S. C.; Binder, L. I. Phosphorylation determines two distinct species of tau in the central nervous system. Cell Motil. Cytoskel. 8:210-226; 1987.
36. Paules, R. S.; Buccione, R.; Moschel, R. C.; Vande Woude, G. F.; Eppig, J. J. Mouse Mos protooncogene product is present and functions during oogenesis. Proc. Natl. Acad. Sci. USA 86:5395-5399; 1989.
37. Pollanen, M. S.; Dickson, D. W.; Bergeron, C. Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol. 52:183-191; 1993.
38. Posada, J.; Yew, N.; Ahn, N. G.; Vande Woude, G. F.; Cooper, J. A. Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase kinase in vitro. Mol. Cell. Biol. 13:2546-2553; 1993.
39. Propst, F.; Cork, L. C.; Kovatch, R. M.; Kasenally, A. B.; Wallace, R.; Rosenberg, M. P. Progressive hind limb paralysis in mice carrying a v-Mos transgene. J. Neuropathol. Exp. Neurol. 51:499-505; 1992.
40. Propst, F.; Rosenberg, M. P.; Cork, L. C.; Kovatch, R. M.; Rauch, S.; Westphal, H.; Khillan, J.; Schulz, N. T.; Vande Woude, G. F.; Newmann, P. E. Neuropathological changes in transgenic mice carrying copies of a transcriptionally activated Mos protooncogene. Proc. Natl. Acad. Sci. USA 87:9703-9707; 1990.
41. xe proto-oncogene product. Cell 61:825-831; 1990.
42. Sagata, N.; Oskarsson, M.; Copeland, T.; Brumbaugh, J.; Vande Woude, G. F. Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes. Nature 335:519-525; 1988.
43. Sagata, N.; Watanabe, N.; Vande Woude, G. F.; Ikawa, Y. The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs. Nature 342:512-518; 1989.
44. Salmhofer, H.; Rainer, I.; Zatloukal, K.; Denk, H. Posttranslational events involved in griseofulvin-induced keratin cytoskeleton alterations. Hepatology 20:731-740; 1994.
45. Schiffer, D.; Giordana, M. T.; Mauro, A.; Migheli, A.; Germano, I.; Giaccone, G. Immunohistochemical demonstration of vimentin in human cerebral tumors. Acta Neuropathol. Berl. 70:209-219; 1986.
46. Shibuya, E. K.; Ruderman, J. V. Mos induces the in vitro activation of mitogen-activated protein kinases in lysates of frog oocytes and mammalian somatic cells. Mol. Biol. Cell 4:781-790; 1993.
47. mos protein kinase in vitro and generation of a 50-kDa cleavage product in v-mos-transformed cells. Virology 173:144-156; 1989.
48. Smith, C.; Anderton, B. H. The molecular pathology of Alzheimer's disease: Are we any closer to understanding the neurodegenerative process. Neuropathol. Appl. Neurobiol. 20:322-338; 1994.
49. Sobue, G.; Hashizume, Y.; Yasuda, T.; Mukai, E.; Kumagi, T.; Mitsuma, T.; Trojanowski, J. Q. Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells. Acta Neuropathol. Berl. 79:402-408; 1990.
50. Southern, E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517; 1975.
51. Sternberger, L. A.; Sternberger, N. H. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc. Natl. Acad. Sci. USA 80:6126-6130; 1983.
52. Trojanowski, J. Q.; Schmidt, M. L.; Ryong-Woon, S.; Brainblett, G. T.; Rao, D.; Lee, V. M. Y. Altered tau and neurofilament proteins in neurodegenerative diseases: Diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol. 3:45-54; 1993.
53. Yew, N.; Mellini, M.; Vande Woude, G. F. Meiotic initiation by the mos protein in Xenopus. Nature 355:649-652; 1992.
54. Yew, N.; Oskarsson, M.: Daar, I.; Blair, D. G.; Vande Woude, G. F. mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities. Mol. Cell. Biol. 11:604-610; 1991.
55. Yung, W. K.; Luna, M.; Borit, A. Vimentin and glial fibrillary acidic protein in human brain tumors. J. Neurooncol. 3:35-38; 1985.
56. Zhao, X.; Batten, B.; Singh, B.; Arlinghaus, R. B. Requirement of the c-mos protein kinase for murine meiotic maturation. Oncogene 5: 1727-1730; 1990.
57. mos association with tubulin. Cell Growth Diff. 2:257-265; 1991.